BIOANALYTICAL SYS INC's ticker is BASI and the CUSIP is 09058M103. A total of 18 filers reported holding BIOANALYTICAL SYS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,000 | – | 52 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 52 | -55.2% | 0.00% | – |
| Q2 2020 | $0 | – | 116 | +123.1% | 0.00% | – |
| Q1 2020 | $0 | – | 52 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 52 | -90.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 518 | +896.2% | 0.00% | – |
| Q2 2019 | $0 | – | 52 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 52 | -25.7% | 0.00% | – |
| Q4 2018 | $0 | – | 70 | +34.6% | 0.00% | – |
| Q3 2018 | $0 | – | 52 | -5.5% | 0.00% | – |
| Q2 2018 | $0 | – | 55 | +5.8% | 0.00% | – |
| Q1 2018 | $0 | – | 52 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 52 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 52 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 52 | +5100.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q1 2016 | $1,000 | – | 883 | +17560.0% | 0.00% | – |
| Q2 2015 | $0 | – | 5 | -95.2% | 0.00% | – |
| Q4 2013 | $0 | – | 105 | +20.7% | 0.00% | – |
| Q3 2013 | $0 | -100.0% | 87 | -93.9% | 0.00% | – |
| Q2 2013 | $2,000 | – | 1,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH STAR ASSET MANAGEMENT INC | 20,000 | $54,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 3 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 54,038 | $146,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 100 | $271,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 105 | $0 | 0.00% |
| STATE STREET CORP | 22,800 | $46,000 | 0.00% |
| MORGAN STANLEY | 24,814 | $67,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 230 | $1,000 | 0.00% |
| Renaissance Technologies | 16,800 | $46,000 | 0.00% |
| BARCLAYS PLC | 83 | $0 | 0.00% |